Primary Site >> Pancreatic Cancer

Gene >> FLT1

Journal: Gastroenterology. 2000 Nov;119(5):1358-72.
Title: De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.
Author: von Marschall, Z|Cramer, T|Hocker, M|Burde, R|Plath, T|Schirner, M|Heidenreich, R|Breier, G|Riecken, E O|Wiedenmann, B|Rosewicz, S
PMID: 11054395
Journal: Int J Cancer. 2000 Jan 1;85(1):27-34.
Title: Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
Author: Itakura, J|Ishiwata, T|Shen, B|Kornmann, M|Korc, M
PMID: 10585578
Journal: Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4605-10. Epub 2001 Mar 27.
Title: Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer.
Author: Kuo, C J|Farnebo, F|Yu, E Y|Christofferson, R|Swearingen, R A|Carter, R|von Recum, H A|Yuan, J|Kamihara, J|Flynn, E|D'Amato, R|Folkman, J|Mulligan, R C
PMID: 11274374
Journal: Pancreas. 2002 Aug;25(2):111-21.
Title: Gene therapy for pancreatic cancer using an adenovirus vector encoding soluble flt-1 vascular endothelial growth factor receptor.
Author: Hoshida, Tohru|Sunamura, Makoto|Duda, Dan G|Egawa, Shinichi|Miyazaki, Shukichi|Shineha, Ryuzaburo|Hamada, Hirofumi|Ohtani, Haruo|Satomi, Susumu|Matsuno, Seiki
PMID: 12142732
Journal: Eur J Nucl Med Mol Imaging. 2002 Sep;29(9):1174-81.
Title: Evaluation of pyrimidine metabolising enzymes and in vitro uptake of 3'-[(18)F]fluoro-3'-deoxythymidine ([(18)F]FLT) in pancreatic cancer cell lines.
Author: Seitz, Ulrike|Wagner, Martin|Neumaier, Bernd|Wawra, Edgar|Glatting, Gerhard|Leder, Gerhard|Schmid, Roland M|Reske, Sven N
PMID: 12192562
Journal: Cancer Res. 2003 Sep 15;63(18):5978-91.
Title: CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Author: Ruggeri, Bruce|Singh, Jasbir|Gingrich, Diane|Angeles, Thelma|Albom, Mark|Yang, Shi|Chang, Hong|Robinson, Candy|Hunter, Kathryn|Dobrzanski, Pawel|Jones-Bolin, Susan|Pritchard, Sonya|Aimone, Lisa|Klein-Szanto, Andres|Herbert, Jean-Marc|Bono, Francoise|Schae
PMID: 14522925
Journal: Clin Cancer Res. 2004 May 15;10(10):3327-32.
Title: Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines.
Author: Fukasawa, Mitsuharu|Korc, Murray
PMID: 15161686
Journal: Cancer. 2005 Jul 15;104(2):427-38.
Title: Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines.
Author: Wey, Jane S|Fan, Fan|Gray, Michael J|Bauer, Todd W|McCarty, Marya F|Somcio, Ray|Liu, Wenbiao|Evans, Douglas B|Wu, Yan|Hicklin, Daniel J|Ellis, Lee M
PMID: 15952180
Journal: Cancer. 2006 Apr 15;106(8):1677-84.
Title: Vascular endothelial growth factor, FLT-1, and FLK-1 analysis in a pancreatic cancer tissue microarray.
Author: Chung, Gina G|Yoon, Harry H|Zerkowski, Maciej P|Ghosh, Sriparna|Thomas, Laurie|Harigopal, Malini|Charette, Lori A|Salem, Ronald R|Camp, Robert L|Rimm, David L|Burtness, Barbara A
PMID: 16532435
Journal: Cancer Res. 2007 Apr 1;67(7):3286-94.
Title: Regulation of vascular endothelial growth factor receptor-1 expression by specificity proteins 1, 3, and 4 in pancreatic cancer cells.
Author: Abdelrahim, Maen|Baker, Cheryl H|Abbruzzese, James L|Sheikh-Hamad, David|Liu, Shengxi|Cho, Sung Dae|Yoon, Kyungsil|Safe, Stephen
PMID: 17409437
Journal: Mol Pharm. 2010 Apr 5;7(2):501-9.
Title: Antiangiogenic gene therapy of solid tumor by systemic injection of polyplex micelles loading plasmid DNA encoding soluble flt-1.
Author: Oba, Makoto|Vachutinsky, Yelena|Miyata, Kanjiro|Kano, Mitsunobu R|Ikeda, Sorato|Nishiyama, Nobuhiro|Itaka, Keiji|Miyazono, Kohei|Koyama, Hiroyuki|Kataoka, Kazunori
PMID: 20178335
Journal: Cancer Sci. 2010 Jun;101(6):1529-35.
Title: Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer.
Author: Doi, Yosuke|Yashiro, Masakazu|Yamada, Nobuya|Amano, Ryosuke|Ohira, Go|Komoto, Masahiro|Noda, Satoru|Kashiwagi, Shinichiro|Kato, Yukihiro|Fuyuhiro, Yuhiko|Hirakawa, Kosei
PMID: 20367641
Journal: J Exp Clin Cancer Res. 2010 May 23;29:53.
Title: RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells.
Author: Yamazoe, Sadaaki|Tanaka, Hiroaki|Sawada, Tetsuji|Amano, Ryosuke|Yamada, Nobuya|Ohira, Masaichi|Hirakawa, Kosei
PMID: 20492722
Journal: Cancer Res. 2010 Aug 1;70(15):6283-92.
Title: Transplanting normal vascular proangiogenic cells to tumor-bearing mice triggers vascular remodeling and reduces hypoxia in tumors.
Author: Sasajima, Junpei|Mizukami, Yusuke|Sugiyama, Yoshiaki|Nakamura, Kazumasa|Kawamoto, Toru|Koizumi, Kazuya|Fujii, Rie|Motomura, Wataru|Sato, Kazuya|Suzuki, Yasuaki|Tanno, Satoshi|Fujiya, Mikihiro|Sasaki, Katsunori|Shimizu, Norihiko|Karasaki, Hidenori|Kono, To
PMID: 20631070
Journal: Clin J Gastroenterol. 2010 Dec;3(6):307-17.
Title: Gastrointestinal bleeding during anti-angiogenic peptide vaccination in combination with gemcitabine for advanced pancreatic cancer.
Author: Nagayama, Hitomi|Matsumoto, Kazufumi|Isoo, Naoyuki|Ohno, Hideki|Takahashi, Naoyuki|Nakaoka, Takashi|Shinozaki, Masaru|Watanabe, Makoto|Inoue, Yusuke|Nagamura, Fumitaka|Oyaizu, Naoki|Yamashita, Naohide
PMID: 26190488
Journal: BMC Cancer. 2011 Jul 5;11:286.
Title: Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.
Author: Rahbari, Nuh N|Schmidt, Thomas|Falk, Christine S|Hinz, Ulf|Herber, Magdalene|Bork, Ulrich|Buchler, Markus W|Weitz, Jurgen|Koch, Moritz
PMID: 21729304
Journal: Clin Cancer Res. 2012 May 15;18(10):2838-49.
Title: Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
Author: Speisky, Daniela|Duces, Aurelie|Bieche, Ivan|Rebours, Vinciane|Hammel, Pascal|Sauvanet, Alain|Richard, Stephane|Bedossa, Pierre|Vidaud, Michel|Murat, Arnaud|Niccoli, Patricia|Scoazec, Jean-Yves|Ruszniewski, Philippe|Couvelard, Anne
PMID: 22461457
Journal: Pancreas. 2013 Apr;42(3):411-21.
Title: Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
Author: Gilbert, Judith A|Adhikari, Laura J|Lloyd, Ricardo V|Halfdanarson, Thorvardur R|Muders, Michael H|Ames, Matthew M
PMID: 23211371
Journal: Oncoimmunology. 2013 Nov 1;2(11):e27010.
Title: Immunological responses to a multi-peptide vaccine targeting cancer-testis antigens and VEGFRs in advanced pancreatic cancer patients.
Author: Okuyama, Ryuji|Aruga, Atsushi|Hatori, Takashi|Takeda, Kazuyoshi|Yamamoto, Masakazu
PMID: 24498547
Journal: PLoS One. 2013 Sep 9;8(9):e73940.
Title: DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer.
Author: Sureban, Sripathi M|May, Randal|Qu, Dongfeng|Weygant, Nathaniel|Chandrakesan, Parthasarathy|Ali, Naushad|Lightfoot, Stan A|Pantazis, Panayotis|Rao, Chinthalapally V|Postier, Russell G|Houchen, Courtney W
PMID: 24040120
Journal: Acta Oncol. 2014 Jan;53(1):103-12.
Title: VEGFR1 single nucleotide polymorphisms associated with outcome in patients with metastatic renal cell carcinoma treated with sunitinib - a multicentric retrospective analysis.
Author: Beuselinck, Benoit|Karadimou, Alexandra|Lambrechts, Diether|Claes, Bart|Wolter, Pascal|Couchy, Gabrielle|Berkers, Joost|van Poppel, Hendrik|Paridaens, Robert|Schoffski, Patrick|Mejean, Arnaud|Verkarre, Virginie|Lerut, Evelyne|Joly, Florence|Lebret, Thierr
PMID: 23421954
Journal: Cancer Lett. 2014 Aug 28;351(1):151-61.
Title: XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.
Author: Sureban, Sripathi M|May, Randal|Weygant, Nathaniel|Qu, Dongfeng|Chandrakesan, Parthasarathy|Bannerman-Menson, Eddie|Ali, Naushad|Pantazis, Panayotis|Westphalen, Christoph B|Wang, Timothy C|Houchen, Courtney W
PMID: 24880079
Journal: J Pathol. 2014 Oct;234(2):214-27.
Title: Parp-1 genetic ablation in Ela-myc mice unveils novel roles for Parp-1 in pancreatic cancer.
Author: Martinez-Bosch, Neus|Iglesias, Mar|Munne-Collado, Jessica|Martinez-Caceres, Carlos|Moreno, Mireia|Guerra, Carmen|Yelamos, Jose|Navarro, Pilar
PMID: 24889936
Journal: Vasc Cell. 2014 Sep 6;6:18.
Title: Lenvatinib, an angiogenesis inhibitor targeting VEGFR/FGFR, shows broad antitumor activity in human tumor xenograft models associated with microvessel density and pericyte coverage.
Author: Yamamoto, Yuji|Matsui, Junji|Matsushima, Tomohiro|Obaishi, Hiroshi|Miyazaki, Kazuki|Nakamura, Katsuji|Tohyama, Osamu|Semba, Taro|Yamaguchi, Atsumi|Hoshi, Sachi Suzuki|Mimura, Fusayo|Haneda, Toru|Fukuda, Yoshio|Kamata, Jun-Ichi|Takahashi, Keiko|Matsukura,
PMID: 25197551
Journal: Cancer Lett. 2015 Mar 1;358(1):59-66.
Title: Nintedanib, a triple angiokinase inhibitor, enhances cytotoxic therapy response in pancreatic cancer.
Author: Awasthi, Niranjan|Hinz, Stefan|Brekken, Rolf A|Schwarz, Margaret A|Schwarz, Roderich E
PMID: 25527450
Journal: Mol Imaging Radionucl Ther. 2015 Jun 5;24(2):71-9.
Title: Proliferative and Glycolytic Assessment of the Whole-Body Bone Marrow Compartment.
Author: Goryawala, Mohammed|Adjoua, Malek|Gulec, Seza
PMID: 26316472
Journal: Rom J Intern Med. 2015 Jul-Sep;53(3):199-208.
Title: VEGF Expression in Pancreatic Cancer and Other Malignancies: A Review of the Literature.
Author: Costache, M I|Ioana, Mihai|Iordache, Sevastita|Ene, D|Costache, Cornelia Alexandra|Saftoiu, A
PMID: 26710495
Journal: Mol Imaging Radionucl Ther. 2016 Feb 5;25(1):32-8.
Title: 18F-FLT Positron Emission Tomography/Computed Tomography Imaging in Pancreatic Cancer: Determination of Tumor Proliferative Activity and Comparison with Glycolytic Activity as Measured by 18F-FDG Positron Emission Tomography/Computed Tomography Imaging.
Author: Debebe, Senait Aknaw|Goryawala, Mohammed|Adjouadi, Malek|Mcgoron, Anthony J|Gulec, Seza A
PMID: 27299286
Journal: Oncotarget. 2016 Nov 15;7(46):75319-75327.
Title: Tumor-specific gene therapy for pancreatic cancer using human neural stem cells encoding carboxylesterase.
Author: Choi, Sung S|Yoon, Kichul|Choi, Seon-A|Yoon, Seung-Bin|Kim, Seung U|Lee, Hong J
PMID: 27659534
Journal: Cancer Sci. 2017 Jan;108(1):73-80.
Title: Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.
Author: Suzuki, Nobuaki|Hazama, Shoichi|Iguchi, Haruo|Uesugi, Kazuhiro|Tanaka, Hiroaki|Hirakawa, Kosei|Aruga, Atsushi|Hatori, Takashi|Ishizaki, Hidenobu|Umeda, Yuzo|Fujiwara, Toshiyoshi|Ikemoto, Tetsuya|Shimada, Mitsuo|Yoshimatsu, Kazuhiko|Shimizu, Ryoichi|Hayash
PMID: 27783849
Journal: J Control Release. 2017 Jan 10;245:1-14.
Title: Triple-amiRNA VEGFRs inhibition in pancreatic cancer improves the efficacy of chemotherapy through EMT regulation.
Author: Huang, Jianfei|Mei, Haijun|Tang, Zhiyuan|Li, Jieying|Zhang, Xiaojing|Lu, Yixiang|Huang, Fang|Jin, Qin|Wang, Zhiwei
PMID: 27889393
Journal: Int J Pharm. 2017 Jan 30;517(1-2):157-167.
Title: Effective targeting of gemcitabine to pancreatic cancer through PEG-cored Flt-1 antibody-conjugated dendrimers.
Author: Ozturk, Kivilcim|Esendagli, Gunes|Gurbuz, Mustafa Ulvi|Tulu, Metin|Calis, Sema
PMID: 27965135
Journal: Oncol Lett. 2017 Oct;14(4):4647-4658.
Title: TNFalpha and TGFbeta-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells.
Author: Kali, Aikyn|Ostapchuk, Yekaterina O|Belyaev, Nikolai N
PMID: 29085463
Journal: Mol Pharm. 2018 Apr 2;15(4):1526-1533.
Title: Tumor-Induced Myeloid Cells Are Reduced by Gemcitabine-Loaded PAMAM Dendrimers Decorated with Anti-Flt1 Antibody.
Author: Yoyen-Ermis, Digdem|Ozturk-Atar, Kivilcim|Kursunel, M Alper|Aydin, Cisel|Ozkazanc, Didem|Gurbuz, Mustafa Ulvi|Uner, Aysegul|Tulu, Metin|Calis, Sema|Esendagli, Gunes
PMID: 29481086